Proclarix - Next generation blood test for prostate cancer
Proteomedix AG
Incorporated
24.03.2010Headquarters
SchlierenSupport
Proteomedix is a healthcare company whose mission is to transform prostate cancer diagnosis. The company has identified novel biomarker signatures with utility in prostate cancer diagnosis, prognosis and therapy management. The lead product Proclarix® is a blood based prostate cancer test panel and risk score currently available in Europe. Proteomedix is located in the Bio-Technopark of Zurich-Schlieren, Switzerland. For more information, visit www.proteomedix.com.
Sectors
Awards
News
Swiss diagnostics company Proteomedix has officially joined forces with Blue Water Biotech to create Onconetix (venturekick.ch)
Proteomedix acquired by US company (startupticker.ch)
Proteomedix set for growth (startupticker.ch)
Proclarix on the way to a worldwide standard (startupticker.ch)
Chinese cancer screening company invests in Proteomedix (startupticker.ch)
Industry experts take the lead in startups' management (startupticker.ch)
Erstes Labor setzt auf Prostata-Test von Proteomedix (startupticker.ch)
Proteomedix announces commercial launch of its blood-based test for prostate cancer (startupticker.ch)
Proteomedix appoints new CEO to launch their diagnostic test (startupticker.ch)
ProteoMediX Raises CHF 5.2 million in Financing Round (startupticker.ch)
Proteomedix? prostate cancer test could avoid a large number of biopsies (startupticker.ch)
Proteomedix‘ test may lower rate of negative prostate biopsies by more than 50% (startupticker.ch)
ProteoMediX Raises CHF 5 million in Financing Round (startupticker.ch)
ProteoMediX Raises CHF 1.0 million in Extended Series B Financing (startupticker.ch)
CTI supports the development of a prostate cancer risk stratification test (startupticker.ch)
ProteoMediX Raises CHF 3.2 million in Series B Financing (startupticker.ch)
Die Finalisten des Swiss Technology Award 2012 stehen fest (startupticker.ch)
Sieben Mal 100 000 Franken für Gründer (startupticker.ch)
Grosses Interesse an Schweizer Start-ups (startupticker.ch)
Milestones news
Proteomedix and New Horizon Health Limited enter into a research and development partnership.
ProteoMediX Raises CHF 1.0 million in Extended Series B Financing
Videos and Presentations
ProteoMediX - Enabling Personalized Medicine
ProteoMediX: Finalist zkb pionierpreis technopark 2013